A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura Gault, MD, PhD, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 6109
Mesa, Arizona, United States
- Site Reference Id/investigator# 6765
Mesa, Arizona, United States
- Site Reference Id/investigator# 6100
Lafayette, California, United States
- Site Reference Id/investigator# 6107
San Diego, California, United States
- Site Reference Id/investigator# 6112
Jacksonville, Florida, United States
- Site Reference Id/investigator# 6096
Maitland, Florida, United States
- Site Reference Id/investigator# 6105
Tampa, Florida, United States
- Site Reference Id/investigator# 6094
Smyrna, Georgia, United States
- Site Reference Id/investigator# 6111
Newton, Kansas, United States
- Site Reference Id/investigator# 6113
Farmington Hills, Michigan, United States
- Site Reference Id/investigator# 6110
Omaha, Nebraska, United States
- Site Reference Id/investigator# 6099
New York, New York, United States
- Site Reference Id/investigator# 6106
Chapel Hill, North Carolina, United States
- Site Reference Id/investigator# 6102
Portland, Oregon, United States
- Site Reference Id/investigator# 6097
Charleston, South Carolina, United States
- Site Reference Id/investigator# 6098
Memphis, Tennessee, United States
- Site Reference Id/investigator# 6103
Austin, Texas, United States
- Site Reference Id/investigator# 6104
Lake Jackson, Texas, United States
- Site Reference Id/investigator# 6095
Herndon, Virginia, United States
- Site Reference Id/investigator# 6092
Seattle, Washington, United States
- Site Reference Id/investigator# 6101
Middleton, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2007
- Primary completion
- 31 Oct 2008
- Completion
- 31 Oct 2008
- Last update posted
- 18 Jan 2013
- Registered enrollment
- 141
- Registry id
- NCT00443391
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.